You have not yet added any article to your bookmarks!
Join 10k+ people to get notified about new posts, news and tips.
Do not worry we don't spam!
Post by : Shakul
Artificial intelligence, scientific talent and cross-disciplinary innovation are rapidly transforming the biomanufacturing sector across the Asia-Pacific region, according to industry experts speaking at a major regional summit in Singapore.
At the APAC Biomanufacturing Leadership Summit, investors and scientists discussed how emerging technologies are reshaping the life sciences ecosystem. The event brought together global biotechnology leaders, researchers and venture capital firms to explore new developments in biotechnology and pharmaceutical manufacturing.
During the summit, Richard Yang, managing partner at Sinovation Ventures, highlighted the growing influence of artificial intelligence and advanced technologies in life sciences. He noted that Asia has seen a wave of globally trained scientists returning from the United States and Europe, contributing to research, innovation and startup growth across the region.
Experts say one of the most significant trends shaping the sector is the convergence of disciplines. Professionals from fields such as robotics, data science and artificial intelligence are increasingly working alongside biologists and medical researchers. This integration is accelerating breakthroughs in drug discovery, biotechnology research and advanced manufacturing processes.
Artificial intelligence is playing a key role in analysing massive biological datasets, helping researchers better understand complex biological systems. AI-driven robotics platforms are also being adopted in laboratories and manufacturing facilities to automate experiments, speed up production and improve efficiency.
Industry leaders believe this technological shift could significantly reshape how biotechnology companies operate over the next two decades. The combination of AI-driven discovery, automated research systems and advanced data analysis tools is expected to reduce development timelines and increase the success rate of new therapies.
Singapore and other innovation hubs in the Asia-Pacific region are positioning themselves as major centres for biotechnology investment and collaboration. Experts say regional platforms such as the summit are important for connecting scientists, investors and entrepreneurs who are working to translate scientific discoveries into scalable biotech companies.
As biotechnology continues to merge with artificial intelligence and advanced engineering, analysts expect Asia-Pacific to play an increasingly influential role in the global life sciences industry.
Union of European Clubs Challenge UEFA and EFC Over EU Competition Rules
UEC files an EU competition complaint against UEFA and EFC, challenging club representation, governa
Mohammed Shami Retires From Test Cricket, Eyes White-Ball Career
Mohammed Shami retires from Test cricket after 13 years, with 229 wickets. He will continue playing
Singapore Warns Users About Privacy and Security Risks of AI Agents
Singapore warns users about AI agent security risks, data privacy, online scams and unauthorised acc
Chris Lynn Completes One-Month Ban After Positive Cocaine Test
Australian cricketer Chris Lynn completes a one-month ban after a positive cocaine test during the T
Djokovic Eyes Strong Season Finish as Health Improves Ahead of Paris Masters
Novak Djokovic reports improved health and performance as he targets a strong Paris Masters finish a
SpaceX in Talks to Buy Boost Mobile or Use Its Network
SpaceX reportedly explores a Boost Mobile deal with EchoStar to expand Starlink Mobile and challenge